STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Exact Sciences to participate in June investor conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

MADISON, Wis., June 1, 2023 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

  • Jefferies Healthcare Conference, New York
    Fireside chat on Wednesday, June 7, 2023 at 2:00 p.m. ET

  • William Blair 43rd Annual Growth Stock Conference, Chicago
    Presentation on Wednesday, June 7, 2023 at 4:20 p.m. ET

  • Goldman Sachs 44th Annual Global Healthcare Conference, Dana Point
    Fireside chat on Tuesday, June 13, 2023 at 4:20 p.m. ET

The webcasts can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com.

About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-june-investor-conferences-301839512.html

SOURCE Exact Sciences Corporation

Exact Sciences Corp

NASDAQ:EXAS

EXAS Rankings

EXAS Latest News

EXAS Latest SEC Filings

EXAS Stock Data

12.61B
187.14M
0.91%
95.62%
3.88%
Diagnostics & Research
Services-medical Laboratories
Link
United States
MADISON